Anaesthesia and Intensive Care Unit of Emergency Department, Careggi Teaching Hospital, Florence, Italy.
Scand J Trauma Resusc Emerg Med. 2010 May 21;18:28. doi: 10.1186/1757-7241-18-28.
Extracorporeal Life Support (ECLS) and extracorporeal membrane oxygenation (ECMO) have been indicated as treatment for acute respiratory and/or cardiac failure. Here we describe our first year experience of in-hospital ECLS activity, the operative algorithm and the protocol for centralization of adult patients from district hospitals.
At a tertiary referral trauma center (Careggi Teaching Hospital, Florence, Italy), an ECLS program was developed from 2008 by the Emergency Department and Heart and Vessel Department ICUs. The ECLS team consists of an intensivist, a cardiac surgeon, a cardiologist and a perfusionist, all trained in ECLS technique. ECMO support was applied in case of severe acute respiratory distress syndrome (ARDS) not responsive to conventional treatments. The use of veno-arterial (V-A) ECLS for cardiac support was reserved for cases of cardiac shock refractory to standard treatment and cardiac arrests not responding to conventional resuscitation.
A total of 21 patients were treated with ECLS during the first year of activity. Among them, 13 received ECMO for ARDS (5 H1N1-virus related), with a 62% survival. In one case of post-traumatic ARDS, V-A ECLS support permitted multiple organ donation after cerebral death was confirmed. Patients treated with V-A ECLS due to cardiogenic shock (N = 4) had a survival rate of 50%. No patients on V-A ECLS support after cardiac arrest survived (N = 4).
In our centre, an ECLS Service was instituted over a relatively limited period of time. A strict collaboration between different specialists can be regarded as a key feature to efficiently implement the process.
体外生命支持(ECLS)和体外膜氧合(ECMO)已被证明是治疗急性呼吸和/或心力衰竭的方法。在这里,我们描述了我们在医院内进行 ECLS 活动的第一年经验、手术算法以及将来自地区医院的成年患者集中到中心的方案。
在一家三级转诊创伤中心(意大利佛罗伦萨的 Careggi 教学医院),一个 ECLS 项目由急诊部和心脏血管科 ICU 于 2008 年开发。ECLS 团队由一名重症监护医师、一名心脏外科医生、一名心脏病专家和一名灌注师组成,他们都接受过 ECLS 技术的培训。ECMO 支持应用于对常规治疗无反应的严重急性呼吸窘迫综合征(ARDS)。静脉-动脉(V-A)ECLS 用于心脏支持仅用于对标准治疗无反应的心脏休克和对常规复苏无反应的心脏骤停。
在活动的第一年,共有 21 名患者接受了 ECLS 治疗。其中,13 名患者因 ARDS 接受 ECMO 治疗(5 例与 H1N1 病毒相关),存活率为 62%。在一例创伤后 ARDS 中,V-A ECLS 支持在脑死亡确认后允许进行多器官捐献。因心源性休克接受 V-A ECLS 治疗的患者(N=4)的存活率为 50%。没有在心脏骤停后接受 V-A ECLS 支持的患者存活(N=4)。
在我们中心,ECLS 服务在相对较短的时间内建立。不同专家之间的严格合作可以被视为有效实施该过程的关键特征。